IRVINE, Calif., July 24 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. today announced that it will release second quarter 2006 financial results on August 3, 2006 before the U.S. markets open. ISTA will host a conference call with a simultaneous webcast to discuss these results at 10:30 AM Eastern Time on August 3, 2006.
To access the live conference call, U.S. and Canadian participants may dial 866-831-6243; international participants may dial 617-213-8855. The access code for the live call is 51958019. To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 72935310. This conference call will also be webcast live and archived on ISTA's website for 30 days at http://www.istavision.com.
ABOUT ISTA
ISTA is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products. ISTA's products and product candidates seek to address serious diseases and conditions of the eye, such as dry eye, vitreous hemorrhage, diabetic retinopathy, hyphema, glaucoma, ocular pain and inflammation. Building on this pipeline, ISTA's goal is to continue its growth as a specialty pharmaceutical company through a combination of its own product development efforts and by acquiring complementary products and product candidates. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' Website at http://www.istavision.com.
ISTA Pharmaceuticals, Inc.CONTACT: Vince Anido, +1-949-788-5311, vanido@istavision.com, or LaurenSilvernail, +1-949-788-5302, lsilvernail@istavision.com, both of ISTAPharmaceuticals; or Justin Jackson, Media, jjackson@burnsmc.com, or JulianeSnowden-Andrew, Investors, jsnowden-andrew@burnsmc.com, both of BurnsMcClellan, +1-212-213-0006, for ISTA Pharmaceuticals
Web site: http://www.istavision.com/
